Abstract
Gestational trophoblastic neoplasia (GTN) patients with WHO risk score ≥13, as well as those with brain, liver, or extensive metastasis fall in the ultra high-risk group. Available data on these patients is limited. This study aims to assess the clinical characteristics and prognosis of this group.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have